NH Stock Overview
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom.
Notes are coming soon
NantHealth, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$3.46|
|52 Week High||US$15.75|
|52 Week Low||US$1.57|
|1 Month Change||1.17%|
|3 Month Change||-27.26%|
|1 Year Change||-71.60%|
|3 Year Change||-87.26%|
|5 Year Change||-92.21%|
|Change since IPO||-98.76%|
Recent News & Updates
NantHealth GAAP EPS of -$0.11, revenue of $16.5MAug 04
Ronald Louks Is The Chief Operating Officer of NantHealth, Inc. (NASDAQ:NH) And They Just Sold 26% Of Their SharesMar 18
Time To Worry? Analysts Are Downgrading Their NantHealth, Inc. (NASDAQ:NH) OutlookMar 06
If You Had Bought NantHealth (NASDAQ:NH) Shares A Year Ago You'd Have Earned 183% ReturnsFeb 04
NantHealth jumps after study highlights the utility of its decision-support platformDec 11
|NH||US Healthcare Services||US Market|
Return vs Industry: NH underperformed the US Healthcare Services industry which returned -28.7% over the past year.
Return vs Market: NH underperformed the US Market which returned -9.6% over the past year.
|NH Average Weekly Movement||33.9%|
|Healthcare Services Industry Average Movement||10.4%|
|Market Average Movement||6.7%|
|10% most volatile stocks in US Market||17.5%|
|10% least volatile stocks in US Market||2.8%|
Stable Share Price: NH is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 34% a week.
Volatility Over Time: NH's weekly volatility has increased from 21% to 34% over the past year.
About the Company
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.
NantHealth, Inc. Fundamentals Summary
|NH fundamental statistics|
Is NH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NH income statement (TTM)|
|Cost of Revenue||US$23.39m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-7.64|
|Net Profit Margin||-89.76%|
How did NH perform over the long term?See historical performance and comparison